387122008: Glycopyrronium bromide (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Acetylcholine receptor antagonist\...

\Muscarinic receptor antagonist\Glycopyrronium bromide

\Quaternary ammonium compound with anticholinergic mechanism of action (substance)\Glycopyrronium bromide

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\...

\Antispasmodic (substance)\Glycopyrronium bromide

\Acetylcholine receptor antagonist\Muscarinic receptor antagonist\Glycopyrronium bromide
\Acetylcholine receptor antagonist\Quaternary ammonium compound with anticholinergic mechanism of action (substance)\Glycopyrronium bromide

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Quaternary ammonium compound\Quaternary ammonium compound with anticholinergic mechanism of action (substance)\Glycopyrronium bromide

\Organic compound\Organic nitrogen compound\Quaternary ammonium compound\Quaternary ammonium compound with anticholinergic mechanism of action (substance)\Glycopyrronium bromide

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Glycopyrronium bromide	Is a	Muscarinic receptor antagonist	true	Inferred relationship	Some
Glycopyrronium bromide	Is a	Antispasmodic (substance)	true	Inferred relationship	Some
Glycopyrronium bromide	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Muscarinic receptor antagonist (disposition)	true	Inferred relationship	Some
Glycopyrronium bromide	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Glycopyrronium (substance)	true	Inferred relationship	Some
Glycopyrronium bromide	Is a	Quaternary ammonium compound with anticholinergic mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
glycopyrrolat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium adverse reaction	Causative agent	False	Glycopyrronium bromide	Inferred relationship	Some
Allergy to glycopyrronium	Causative agent	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium bromide [antispasmodic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium bromide [anesthesia]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 200 µg/1 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 600 µg/3 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrrolate 0.2mg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium bromide 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium bromide 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat til oral anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat til parenteral anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrrolate 100%w/w powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
neostigmin + glycopyrronium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 0,2 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 0,2 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 0,2 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 0,2 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 100%/ww pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium bromide	Is a	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium bromide [anesthesia]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium bromide [antispasmodic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 600 µg/3 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
glycopyrrolat 200 µg/1 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Allergy to glycopyrronium	Causative agent	False	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 2 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 1 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing glycopyrronium bromide and neostigmine bromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Product containing formoterol and glycopyrronium bromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Product containing glycopyrronium bromide and indacaterol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Product containing formoterol and glycopyrronium bromide in respiratory dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Product containing glycopyrronium bromide and indacaterol in respiratory dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Glycopyrronium bromide	Inferred relationship	Some
Glycopyrronium bromide 1 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 2 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing precisely glycopyrronium bromide 600 microgram/3 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing precisely glycopyrronium bromide 600 microgram/3 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Glycopyrronium bromide	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Glycopyrronium bromide	Inferred relationship	Some	2
Glycopyrronium bromide 200 microgram/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 200 microgram/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Glycopyrronium bromide	Inferred relationship	Some	1
Glycopyrronium (as glycopyrronium bromide) 320 microgram/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing precisely glycopyrronium (as glycopyrronium bromide) 160 microgram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Glycopyrronium bromide	Inferred relationship	Some	1
Product containing precisely glycopyrronium (as glycopyrronium bromide) 44 microgram/1 actuation conventional release powder for inhalation (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Glycopyrronium bromide	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1481232014	Glycopyrrolate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2672945019	Glycopyrronium bromide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3482237018	Glycopyrronium bromide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3197091000005118	glycopyrrolat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)
4849391000005111	glycopyrroniumbromid	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)